title: Symptomatic cardiac metastasis responding to pazopanib in a patient with renal cell carcinoma.
abstract: We report a case of an 82-year-old man with renal cell carcinoma who developed a cardiac metastasis within the interventricular septum. He had been under watchful waiting for indolent metastatic renal cell carcinoma for many years before developing symptoms consistent with heart failure. At this time, a 44 mm interventricular septal mass, consistent with a cardiac metastasis, was identified as the cause of his symptoms. Pazopanib was initiated which led to both a clinical and radiological response.
authors.affiliation: Department of Medical Oncology, The Royal Melbourne Hospital, Grattan St, Parkville, Victoria, Australia.
authors.forename: Ramin
authors.initials: R
authors.lastname: Behzadigohar
authors.forename: Mark A
authors.initials: MA
authors.lastname: Rosenthal
authors.forename: Ben
authors.initials: B
authors.lastname: Tran
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D006338:Heart Neoplasms / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000473:pathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000556:secondary* / Q000628:therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D057832:Watchful Waiting
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib